<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font25 { font-size : 25; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">patients </span>
   <span class="font25">(). </span>
   <span class="font25">HCV </span>
   <span class="font21">liver </span>
   <span class="font20">therapy </span>
   <span class="font20">treatment </span>
   <span class="font20">infection </span>
   <span class="font19">DAAs </span>
   <span class="font18">disease </span>
   <span class="font18">thalassemia </span>
   <span class="font18">{border-style </span>
   <span class="font17">genotype </span>
   <span class="font17">px;} </span>
   <span class="font16">#ffffff;} </span>
   <span class="font16">(.%) </span>
   <span class="font16">al.. </span>
   <span class="font16">iron </span>
   <span class="font16">(%) </span>
   <span class="font15">chronic </span>
   <span class="font15">Thalassemia </span>
   <span class="font15">cell </span>
   <span class="font14">hepatitis </span>
   <span class="font14">sickle </span>
   <span class="font14">virus </span>
   <span class="font14">treated </span>
   <span class="font14">SVR </span>
   <span class="font14">antiviral </span>
   <span class="font13">different </span>
   <span class="font13">major </span>
   <span class="font13">patients, </span>
   <span class="font13">study </span>
   <span class="font13">subjects </span>
   <span class="font13">Clin. </span>
   <span class="font13">available </span>
   <span class="font13">genotypes </span>
   <span class="font13">px; </span>
   <span class="font13">ribavirin </span>
   <span class="font13">risk </span>
   <span class="font13">viral </span>
   <span class="font13">{font-family </span>
   <span class="font12">carcinoma </span>
   <span class="font12">days) </span>
   <span class="font12">font-size </span>
   <span class="font12">interferon </span>
   <span class="font12">led </span>
   <span class="font12">overload </span>
   <span class="font12">according </span>
   <span class="font12">blood </span>
   <span class="font12">cirrhosis </span>
   <span class="font12">data </span>
   <span class="font12">did </span>
   <span class="font12">double; </span>
   <span class="font12">efficacy </span>
   <span class="font12">eradication </span>
   <span class="font12">hepatocellular </span>
   <span class="font12">high </span>
   <span class="font12">increase </span>
   <span class="font12">new </span>
   <span class="font12">patient </span>
   <span class="font12">performed </span>
   <span class="font12">subjects), </span>
   <span class="font12">therapies </span>
   <span class="font12">transfusion </span>
   <span class="font12">weeks </span>
   <span class="font12">Agents </span>
   <span class="font12">Antiviral </span>
   <span class="font12">Br. </span>
   <span class="font12">DFO </span>
   <span class="font12">Direct-acting </span>
   <span class="font12">Exp. </span>
   <span class="font12">Hepatitis </span>
   <span class="font12">Hepatol. </span>
   <span class="font12">Italian </span>
   <span class="font12">Liver </span>
   <span class="font12">SCD </span>
   <span class="font12">Table </span>
   <span class="font12">affected </span>
   <span class="font12">border-color </span>
   <span class="font12">border-width </span>
   <span class="font12">chelation </span>
   <span class="font12">clinical </span>
   <span class="font12">complexes </span>
   <span class="font12">disease. </span>
   <span class="font12">patients. </span>
   <span class="font12">plus </span>
   <span class="font12">regimens </span>
   <span class="font12">response </span>
   <span class="font12">solid; </span>
   <span class="font12">treatments </span>
   <span class="font12">{font-style </span>
   <span class="font12">{font-weight </span>
   <span class="font11">(â€“) </span>
   <span class="font11">./j.jceh... </span>
   <span class="font11">Anal. </span>
   <span class="font11">FS, </span>
   <span class="font11">Haematol. </span>
   <span class="font11">Marco </span>
   <span class="font11">Molecular </span>
   <span class="font11">Moreover, </span>
   <span class="font11">Origa </span>
   <span class="font11">Sickle </span>
   <span class="font11">Sofosbivir </span>
   <span class="font11">administration </span>
   <span class="font11">alpha-a </span>
   <span class="font11">analysis </span>
   <span class="font11">approved </span>
   <span class="font11">bold </span>
   <span class="font11">costs </span>
   <span class="font11">courier; </span>
   <span class="font11">defined </span>
   <span class="font11">disease, </span>
   <span class="font11">drugs </span>
   <span class="font11">em; </span>
   <span class="font11">hemolytic </span>
   <span class="font11">hepatic </span>
   <span class="font11">higher </span>
   <span class="font11">induced </span>
   <span class="font11">infection. </span>
   <span class="font11">major. </span>
   <span class="font11">mortality </span>
   <span class="font11">negative </span>
   <span class="font11">pt;} </span>
   <span class="font11">recent </span>
   <span class="font11">serum </span>
   <span class="font11">study. </span>
   <span class="font11">therapy. </span>
   <span class="font11">treat </span>
   <span class="font11">values </span>
   <span class="font11">years </span>
  </p>
 </body>
</html>
